Auxilium adopts poison pill, reaffirms QLT deal after Endo offer
This article was originally published in Scrip
Executive Summary
Auxilium Pharmaceuticals remained committed to its merger with QLT and adopted a "poison pill" to prevent a takeover after it received Endo International's unsolicited $2.2bn buyout offer, which Auxilium said its board of directors will review in consultation with the company's legal and financial advisors.